Korro Bio logo
Korro Bio
KRRO | NASDAQ
Chart Builder DCF Calculator
$12.71
-$0.90 (-6.61%)
At close: Nov 16, 2026, 4:00 PM ET
$12.71
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Korro Bio Company Profile

Company profile explained

Company Profile

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

Key Executives

Name Position
Ram Aiyar Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director
Stephanie Engels Chief People Officer
Todd Chappell Chief Operating Officer
Andrew Fraley Co-Founder & Advisor
Gaozhong Zhu SVP of Chemistry, Manufacturing and Controls & Technical Operations
Jean-Francois Formela Co-Founder & Director
Jeffrey Cerio Senior Vice President, General Counsel & Corporate Secretary
Joshua Rosenthal Co-Founder & Advisor
Loic Vincent Chief Scientific Officer
Oliver Dolan Senior Vice President of Finance & Principal Accounting Officer

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 26, 2026 4 Filing
Oct 22, 2026 8-K Current Report
Oct 05, 2026 8-K Current Report
Sep 15, 2026 4 Filing
Sep 14, 2026 4 Filing
Sep 10, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 21, 2026 4 Filing
Aug 19, 2026 8-K Current Report
View All SEC Filings ➞
Korro Bio
Korro Bio logo
Country United States
IPO Date Oct 3, 2019
Industry Biotechnology
Sector Healthcare
Employees 57
CEO Ram Aiyar

Contact Details

60 First Street Cambridge, Massachusetts 02141 United States

Stock Details

Ticker Symbol KRRO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001703647
CUSIP Number 500946108
ISIN Number US5009461089
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.